Vitrin (VIT) antibody
Principal name
Vitrin (VIT) antibody
Ncbi ID
9606, NP_001171440, NM_001177969, NP_001171440.1, NP_001183957.1, NM_028813, NM_053276, NM_001177972, NM_001177970
Available reactivities
Available hosts
Available applications
Paraffin Sections (P), Western blot / Immunoblot (WB)
Background of Vitrin (VIT) antibody
- Kit Component:
- - KN318897G1, Vit gRNA vector 1 in pCas-Guide vector
- KN318897G2, Vit gRNA vector 2 in pCas-Guide vector
- KN318897D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
VITRN antibody (C-term) (AP54513PU-N) immunohistochemistry analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the VITRN antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.
VITRN Antibody (C-term) (AP54513PU-N) western blot analysis in U251 cell line lysates (35 µg/lane). This demonstrates the VITRN antibody detected the VITRN protein (arrow).
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP54513PU-N | Vitrin (VIT) (C-term) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu | P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
 +1 additional image |
|||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY433419 | VIT overexpression lysate |
|
 |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR209763L2V | Lenti ORF particles, Vit (GFP-tagged) - Mouse vitrin (Vit), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,400.00
|
|
| OriGene Technologies, Inc. | ||
| MR209763L1V | Lenti ORF particles, Vit (Myc-DDK-tagged) - Mouse vitrin (Vit), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,250.00
|
|
| OriGene Technologies, Inc. | ||
